Reva touts first implant of Fantom Encore bioresorbable scaffold in Italy

Reva Medical (ASX:RVA) touted this week the first implant of its newly-launched Fantom Encore bioresorbable scaffold in Italy.
The company’s third-generation coronary bioresorbable scaffold features a thin strut profile and Reva’s Tyrocore polymer.
Get the full story at our sister site, Drug Delivery Business News.
The post Reva touts first implant of Fantom Encore bioresorbable scaffold in Italy appeared first on MassDevice.

Source: Mass Device - December 5, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Featured Pharmaceuticals Vascular Wall Street Beat Reva Medical Inc. Source Type: news